Celgene Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$782.4M
Doctors Paid
51,743
Transactions
514,473
2024 Total
$56.5M
Payment Breakdown by Category
Research$653.2M (83.5%)
Royalty/License$21.6M (2.8%)
Consulting$20.2M (2.6%)
Travel$9.9M (1.3%)
Food & Beverage$9.8M (1.3%)
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2019 |
|---|---|---|---|---|
| Dr. Michael Friedman, M.d, M.D | Special Hospital | Pasadena, CA | $1.7M | $0 |
| Julia Haller, M.d, M.D | Retina Specialist | Philadelphia, PA | $1.6M | $0 |
| Dr. Lawrence Green, Md, MD | Procedural Dermatology | Rockville, MD | $571,851 | $0 |
| Dr. Suzanne Fanning, D.o, D.O | Hematology & Oncology | Greenville, SC | $525,885 | $0 |
| Andrew Sulich, Md, MD | Rheumatology | Saint Clair Shores, MI | $486,610 | $0 |
| Amar Majjhoo, Md, MD | Rheumatology | Saint Clair Shores, MI | $461,290 | $0 |
| Mrs. Miriam Bettencourt, Md, MD | Dermatology | Las Vegas, NV | $457,944 | $0 |
| Rebecca Smith, Md, MD | Dermatology | Fort Mill, SC | $445,077 | $0 |
| David Altman, Md, MD | Dermatology | Warren, MI | $442,818 | $0 |
| Dr. John Koo, Md, MD | Dermatology | San Francisco, CA | $434,912 | $0 |
| Dr. Steven Sorscher, Md, MD | Medical Oncology | Winston Salem, NC | $423,767 | $0 |
| Dr. David Andorsky, Md, MD | Hematology & Oncology | Boulder, CO | $406,366 | $0 |
| Dr. Delfin Santos, M.d, M.D | Rheumatology | Rochester, MI | $406,160 | $0 |
| Dr. Jeff Sharman, M.d, M.D | Hematology & Oncology | Eugene, OR | $403,120 | $0 |
| Dr. James Mccloskey, M.d, M.D | Hematology | Hackensack, NJ | $369,078 | $0 |
| Dr. Robert Greenberg, Md, MD | Dermatology | San Ramon, CA | $368,507 | $0 |
| Dr. Robert Vescio, M.d, M.D | Hematology & Oncology | Los Angeles, CA | $337,567 | $0 |
| Dr. Alvin Wells, Md, MD | Rheumatology | Destin, FL | $336,916 | $0 |
| Dale Schaefer, Md, MD | Dermatology | Austin, TX | $334,841 | $0 |
| David Spigel, M.d, M.D | Medical Oncology | Nashville, TN | $334,757 | $0 |
| Dr. Richard Haddad, Md, MD | Specialist | Red Bank, NJ | $331,815 | $0 |
| Steven Gross, Md, MD | Ophthalmology | Palm Harbor, FL | $321,375 | $0 |
| Jana Johnson, M.d, M.D | Dermatology | Sioux Falls, SD | $321,011 | $0 |
| Oliver Kurucz, Md, MD | Rheumatology | Easton, PA | $312,730 | $0 |
| Robert Jotte, Md, MD | Hematology & Oncology | Lone Tree, CO | $301,285 | $0 |
Ad
Top Products
- Revlimid $62.8M
- Otezla $47.5M
Associated Products (68)
- Revlimid $64.0M
- ZEPOSIA $56.2M
- JCAR017 $28.4M
- ABECMA $28.3M
- Abraxane $26.3M
- BB-2121 $17.7M
- Pomalyst $17.1M
- Idhifa $14.8M
- REBLOZYL $13.2M
- CC-122 $9.0M
- Ozanimod $8.0M
- RPC-1063 $7.4M
- CC-486 $6.9M
- GED-0301 $5.8M
- Luspatercept $5.7M
- CC-220 $5.4M
- CAR-T $3.6M
- Vidaza $3.4M
- Durvalumab $3.3M
- Imfinzi $3.2M
- INREBIC $3.0M
- ONUREG $3.0M
- Thalomid $2.9M
- RPC1063 $2.7M
- PDA002 $2.5M
- FCARH143 $2.4M
- CC-90001 $2.3M
- Marizomib $2.2M
- CC-90002 $2.1M
- CC-93269 $1.7M
- CC-92480 $1.7M
- REVLIMID $1.5M
- AG-881 $1.5M
- PNK-007 $1.3M
- Istodax $1.2M
- Inrebic $1.2M
- JCAR024 $1.2M
- CC-90009 $1.2M
- CC-115 $982,323
- Marizomid $923,347
- Sotatercept $816,860
- CC-93538 $797,575
- CC-90007 $741,153
- CC-90006 $716,710
- CC-95251 $590,869
- NDS $495,135
- JCAR015 $469,773
- Fedratinib $402,589
- CC-223 $313,818
- GC $290,558
- JCAR014 $289,624
- ABRAXANE $263,478
- ACY-1215 $258,610
- Tislelizumab $191,250
- CC-90003 $132,953
- CC-90005 $121,507
- UC-961 $116,667
- CC-90010 $80,000
- CC-90011 $52,024
- Glucocorticoid $45,347
- Amrubicin $30,456
- CC-11050 $24,625
- CC-292 $24,011
- Motolimod $20,135
- MCARH171 $17,242
- JNK $16,896
- ACY-241 $16,068
- JTCR016 $15,663
Payment Categories
- Food & Beverage $9.8M
- Consulting $20.2M
- Travel & Lodging $9.9M
- Research $653.2M
- Royalties $21.6M
About Celgene Corporation
Celgene Corporation has made $782.4M in payments to 51,743 healthcare providers, recorded across 514,473 transactions in the CMS Open Payments database. In 2024, the company paid $56.5M. The top product by payment volume is Revlimid ($62.8M).
Payments were distributed across 263 medical specialties. The top specialty by payment amount is Hematology & Oncology ($18.1M to 4,934 doctors).
Payment categories include: Food & Beverage ($9.8M), Consulting ($20.2M), Research ($653.2M), Travel & Lodging ($9.9M), Royalties ($21.6M).
Celgene Corporation is associated with 68 products in the CMS Open Payments database, including Revlimid, ZEPOSIA, and JCAR017.